Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change $ Change
grade B $239.38 0.86% 2.05
AGN closed up 0.86 percent on Monday, March 27, 2017, on 74 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical AGN trend table...

Date Alert Name Type % Chg
Mar 27 Cup with Handle Other 0.00%
Mar 24 Lower Bollinger Band Walk Other 0.86%
Mar 24 Cup with Handle Other 0.86%
Mar 23 50 DMA Support Bullish 1.74%
Mar 23 Stochastic Buy Signal Bullish 1.74%
Mar 23 Lower Bollinger Band Walk Other 1.74%
Mar 23 Cup with Handle Other 1.74%
Mar 23 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.74%
Mar 22 Doji - Bullish? Reversal 2.30%
Mar 22 Lower Bollinger Band Walk Other 2.30%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 277.17
52 Week Low 183.98
Average Volume 3,388,720
200-Day Moving Average 227.7749
50-Day Moving Average 234.2784
20-Day Moving Average 239.9245
10-Day Moving Average 237.441
Average True Range 3.8609
ADX 22.27
+DI 18.5
-DI: 18.41
Chandelier Exit (Long, 3 ATRs) 236.9173
Chandelier Exit (Short, 3 ATRs) 244.5827
Upper Bollinger Band 246.6772
Lower Bollinger Band 233.1718
Percent B (%b) 0.46
Bandwidth 0.05629